140 related articles for article (PubMed ID: 31659493)
21. Simplified NaCl based (68)Ga concentration and labeling procedure for rapid synthesis of (68)Ga radiopharmaceuticals in high radiochemical purity.
Mueller D; Klette I; Baum RP; Gottschaldt M; Schultz MK; Breeman WA
Bioconjug Chem; 2012 Aug; 23(8):1712-7. PubMed ID: 22755505
[TBL] [Abstract][Full Text] [Related]
22. 99Tcm-MAG3: problems with radiochemical purity testing.
Murray T; McKellar K; Owens J; Watson WS; Hilditch TE; Elliott AT
Nucl Med Commun; 2000 Jan; 21(1):71-5. PubMed ID: 10717905
[TBL] [Abstract][Full Text] [Related]
23. In Vivo Evaluation of a Bombesin Analogue Labeled with Ga-68 and Co-55/57.
Dam JH; Olsen BB; Baun C; Høilund-Carlsen PF; Thisgaard H
Mol Imaging Biol; 2016 Jun; 18(3):368-76. PubMed ID: 26561028
[TBL] [Abstract][Full Text] [Related]
24. The effect of selected preparation variables on the radiochemical purity of 99mTc-sestamibi.
Norenberg JP; Vaidya MP; Hladik WB; Pathak DR; Born JL; Anderson TL; Carroll TR
J Nucl Med Technol; 2005 Mar; 33(1):34-41. PubMed ID: 15731019
[TBL] [Abstract][Full Text] [Related]
25. Development of Semiautomated Module for Preparation of
Mukherjee A; Subramanian S; Ambade R; Avhad B; Dash A; Korde A
Cancer Biother Radiopharm; 2017 Feb; 32(1):33-37. PubMed ID: 28128645
[TBL] [Abstract][Full Text] [Related]
26. Automated module radiolabeling of peptides and antibodies with gallium-68, lutetium-177 and iodine-131.
De Decker M; Turner JH
Cancer Biother Radiopharm; 2012 Feb; 27(1):72-6. PubMed ID: 22149590
[TBL] [Abstract][Full Text] [Related]
27. Studies on 177Lu-labeled methylene diphosphonate as potential bone-seeking radiopharmaceutical for bone pain palliation.
Abbasi IA
Nucl Med Biol; 2011 Apr; 38(3):417-25. PubMed ID: 21492790
[TBL] [Abstract][Full Text] [Related]
28. Radiochemical synthesis and preclinical evaluation of
Hajdu I; Angyal J; Szikra D; Kertész I; Malanga M; Fenyvesi É; Szente L; Vecsernyés M; Bácskay I; Váradi J; Fehér P; Ujhelyi Z; Vasvári G; Rusznyák Á; Trencsényi G; Fenyvesi F
Eur J Pharm Sci; 2019 Feb; 128():202-208. PubMed ID: 30521943
[TBL] [Abstract][Full Text] [Related]
29. Quality control and GMP synthesis of
Assadi M; Dadgar H
World J Nucl Med; 2020; 19(2):93-98. PubMed ID: 32939194
[TBL] [Abstract][Full Text] [Related]
30. Characteristics of SnO2-based 68Ge/68Ga generator and aspects of radiolabelling DOTA-peptides.
de Blois E; Sze Chan H; Naidoo C; Prince D; Krenning EP; Breeman WA
Appl Radiat Isot; 2011 Feb; 69(2):308-15. PubMed ID: 21145751
[TBL] [Abstract][Full Text] [Related]
31. In Vitro and In Vivo Characterization of an
Lütje S; Franssen GM; Herrmann K; Boerman OC; Rijpkema M; Gotthardt M; Heskamp S
J Nucl Med; 2019 Jul; 60(7):1017-1022. PubMed ID: 30655329
[TBL] [Abstract][Full Text] [Related]
32. A novel, self-shielded modular radiosynthesis system for fully automated preparation of PET and therapeutic radiopharmaceuticals.
Kroselj M; Socan A; Zaletel K; Dreger T; Knopp R; Gmeiner T; Kolenc Peitl P
Nucl Med Commun; 2016 Feb; 37(2):207-14. PubMed ID: 26443981
[TBL] [Abstract][Full Text] [Related]
33. Comparative study on DOTA-derivatized bombesin analog labeled with 90Y and 177Lu: in vitro and in vivo evaluation.
Koumarianou E; Mikołajczak R; Pawlak D; Zikos X; Bouziotis P; Garnuszek P; Karczmarczyk U; Maurin M; Archimandritis SC
Nucl Med Biol; 2009 Aug; 36(6):591-603. PubMed ID: 19647165
[TBL] [Abstract][Full Text] [Related]
34. Optimised labeling, preclinical and initial clinical aspects of CCK-2 receptor-targeting with 3 radiolabeled peptides.
Breeman WA; Fröberg AC; de Blois E; van Gameren A; Melis M; de Jong M; Maina T; Nock BA; Erion JL; Mäcke HR; Krenning EP
Nucl Med Biol; 2008 Nov; 35(8):839-49. PubMed ID: 19026945
[TBL] [Abstract][Full Text] [Related]
35. Preliminary studies on (177)Lu-labeled sodium pyrophosphate (177Lu-PYP) as a potential bone-seeking radiopharmaceutical for bone pain palliation.
Abbasi IA
Nucl Med Biol; 2012 Aug; 39(6):763-9. PubMed ID: 22459337
[TBL] [Abstract][Full Text] [Related]
36. An optimised radiolabel procedure to prepare (99m)Tc-colloidal rhenium sulphide to improve radiochemical purity.
Hosten B; Roche R; Barre E; Fouque J; Mouraeff Y; Dumont A; Meur CL; Garrigue H; Hassoun S; Nataf V; Smadja C; de Beco V; Felice K; Rizzo-Padoin N
Curr Radiopharm; 2011 Apr; 4(2):144-9. PubMed ID: 22191654
[TBL] [Abstract][Full Text] [Related]
37. Technical note: Assessment of radiation measurement devices for the detection of [
Kupitz D; Einspänner E; Wissel H; Hohn A; Kreissl MC; Grosser OS
Med Phys; 2023 Jan; 50(1):590-599. PubMed ID: 36208077
[TBL] [Abstract][Full Text] [Related]
38. A radio-high-performance liquid chromatography dual-flow cell gamma-detection system for on-line radiochemical purity and labeling efficiency determination.
Lindegren S; Jensen H; Jacobsson L
J Chromatogr A; 2014 Apr; 1337():128-32. PubMed ID: 24630054
[TBL] [Abstract][Full Text] [Related]
39. Deficiencies of product labeling directions for the preparation of radiopharmaceuticals.
Hung JC; Ponto JA; Gadient KR; Frie JA; Aksamit CM; Enquist CL; Carrels KE
J Am Pharm Assoc (2003); 2004; 44(1):30-5. PubMed ID: 14965150
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, stabilization and formulation of [177Lu]Lu-AMBA, a systemic radiotherapeutic agent for Gastrin Releasing Peptide receptor positive tumors.
Chen J; Linder KE; Cagnolini A; Metcalfe E; Raju N; Tweedle MF; Swenson RE
Appl Radiat Isot; 2008 Apr; 66(4):497-505. PubMed ID: 18178448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
